Journal article
Media Hyping and the "Herceptin Access Story": An Analysis of Canadian and UK Newspaper Coverage.
Abstract
In May 2005, preliminary trial results pronouncing the effectiveness of Herceptin (trastuzumab) for treatment of early-stage breast cancer were disseminated at a high-profile scientific meeting. Herceptin was subsequently approved for use in the public healthcare systems of Canada and the United Kingdom, although the differences between the two decision timelines were stark. The authors compared UK and Canadian newspaper coverage of the …
Authors
Abelson J; Collins PA
Journal
Healthcare Policy | Politiques de Santé, Vol. 4, No. 3, pp. e113–e128
Publisher
Longwoods Publishing
Publication Date
February 2009
DOI
10.12927/hcpol.2009.20474
ISSN
1715-6572